Haya Alzeer | Pharmacology | Research Excellence Award

Published on 13/05/202614/05/2026 by Environmental Scientists

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

Haya Alzeer
Researcher	Haya Alzeer
Affiliation	Saudi Food and Drug Authority
Country	Saudi Arabia
Scopus ID	57202029321
Citations	44 by 4 docments
h-index	3
Subject Area	Pharmacology
Event	International Environmental Scientists Award
ORCID	0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeer’s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeer’s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeer’s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

External Links

References

Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259–264.https://doi.org/10.1087/20120404
Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Published on 24/03/202628/03/2026 by Environmental Scientists

Prof. Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Professor Emeritus of the University of Granada | The University of Granada University | Spain

Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design.

Citation Metrics ( Scopus )

4500

3750

3000

2250

1500

750

Citations
3894

h-index
34

i10-index
92

Citations

Documents

h-index

View Google Scholar Profile View ORCID Profile

Featured Publications

Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models

– Journal of Medicinal Chemistry, 2002

Choline kinase inhibitors as a novel approach for antiproliferative drug design

– Oncogene, 1997

Homochiral drugs: a demanding tendency of the pharmaceutical industry

– Current Medicinal Chemistry, 2009

Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells

– Oncogene, 2003

The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner

– PLOS ONE, 2011

Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Published on 13/01/202613/01/2026 by Environmental Scientists

Dr. Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Dr. Faiz Ullah Khan | Pharmacology | Post-Doctoral Fellow at Peking University | Pakistan

Dr. Faiz Ullah Khan is a distinguished researcher and academic in the field of pharmacy and pharmaceutical sciences, currently affiliated with Peking University, where he has made significant contributions to clinical pharmacy, public health, and pharmacovigilance. Dr. Faiz Ullah Khan earned his PhD, MPhil, and PharmD degrees, equipping him with a robust educational foundation in clinical research, drug safety, and evidence-based pharmacy practice. Professionally, Dr. Faiz Ullah Khan has collaborated extensively with leading researchers and institutions globally, including Quaid-i-Azam University, Xi’an Jiaotong University, Prince of Songkla University, Jouf University, and the RCSI School of Pharmacy and Biomolecular Sciences, contributing to numerous international research projects in medication safety, antibiotic stewardship, and disease burden assessments.

Citation Metrics (Google Scholar)

2000

1600

1200

800

400

–

Citations
1659

i10index
45

h-index
23

🟦 Citations 🟥 i10index 🟩 h-index

View Google Scholar Profile

Featured Publications:

Clinical Case Studies on Medication Safety

– Elsevier, 2023 · 245 Citations

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

– Journal of the American College of Cardiology, 2025 · 64 Citations

Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan

– Disaster Medicine and Public Health Preparedness, 2022 · 60 Citations

Global, Regional, and National Trends in Routine Childhood Vaccination Coverage from 1980 to 2023 with Forecasts to 2030: A Systematic Analysis for the Global Burden of Disease

– The Lancet, 2025 · 58 Citations

Knowledge, Attitude and Practices Among Consumers Toward Antibiotics Use and Antibiotic Resistance in Swat, Khyber-Pakhtunkhwa, Pakistan

– Expert Review of Anti-Infective Therapy, 2020 · 58 Citations

Alexandru Florea | Pharmaceutical Products | Research Excellence Award

Published on 02/12/202502/12/2025 by Environmental Scientists

Dr. Alexandru Florea | Pharmaceutical products | Research Excellence Award

Biotehnos SA | Romania

Dr. Alexandru Florea is a dedicated chemist specializing in analytical chemistry, chromatographic techniques, bioanalytical studies, and mesoporous material synthesis, with a strong interdisciplinary background spanning pharmaceutical, environmental, and bioactive compound research. His expertise includes gas and liquid chromatography, tandem mass spectrometry, FT-IR, Raman spectroscopy, and advanced analytical protocols essential for investigating pesticides, heavy metals, and therapeutic compounds in diverse matrices. As an active contributor to research and development, he has participated in multiple national and European scientific projects focused on drug delivery systems, bioactive composites, phytochemical optimization, biopesticides, and innovative materials for medical and industrial applications. His work emphasizes analytical method development, experimental design, and the qualitative and quantitative characterization of natural compounds, pharmaceuticals, and complex mixtures. He has co-authored impactful publications on mesoporous silica composites, volatile oil encapsulation, metal transfer in medicinal plants, pesticide behavior, silica–plant extract composites, and nanoparticle applications in cancer research, demonstrating his ability to integrate chemical analysis with applied biological and pharmaceutical objectives. His research further extends to evaluating contaminants in herbal preparations, optimizing extraction processes, and advancing drug delivery through material engineering. He has gained substantial experience in laboratory management, chromatographic troubleshooting, spectrometric interpretation, and implementing standard operating procedures—reflecting strong organizational and technical skills. Through continued training and engagement in scientific seminars, he has strengthened his proficiency in analytical instrumentation and modern characterization techniques. With 54 citations by 54 documents, 7 published papers, and an h-index of 3, he stands out as a versatile chemist committed to innovation, scientific rigor, and advancing analytical and bioanalytical methodologies within pharmaceutical and environmental chemistry.

Profiles: Scopus | Orcid

Featured Publications

Florea, M.-A., Cristea, S., Perisoara, A., Tihauan, B.-M., Ene, M. D., Constantin, M., Ivan, E. Ș., Zala, R. C., Purcăreanu, B., Mihaiescu, D. E., et al. (2025). In vitro evaluation of the antifungal activity of Trigonella foenum-graecum seed extract and its potential application in plant protection. Plants, 14, 3320.

Purcăreanu, B., Ene, M. D., Moroșan, A., Mihaiescu, D. E., Florea, M.-A., Ghica, A., Niță, R. A., Drumea, V., Grigoroscuta, M. A., Kuncser, A., et al. (2023). Mesoporous composite bioactive compound delivery system for wound-healing processes. Pharmaceutics, 15, 2258.

Florea, M.-A., Drumea, V., Niță, R. A., Olariu, L., Georgiana Oana, T., & Gîrd, C. E. (2021). Transfer of some metals from medicinal plant used in phytotherapy, in different teas preparations. Toxicological and Environmental Chemistry, 103(6), 202–212.

Florea, M.-A. (2021). Optimization of the loading process of Artemisia absinthium volatile oil in a mesoporous material as drug delivery system. Biointerface Research in Applied Chemistry, 12(1), 450–464.

Florea, M.-A., Drumea, V., Niță, A.-R., Olariu, L., Costea, T., & Gîrd, C. E. (2020). Investigation of pesticide residues and heavy metals content in various peppermint samples. Farmacia, 68(4), 663–670.

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Published on 08/10/2024 by Environmental Scientists

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education 🎓

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience 🧑‍🏫

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest 🔬

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards 🏆

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes 📚

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Published on 31/07/202431/07/2024 by Environmental Scientists

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award 🏆. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes 💊. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs 🔬.

PROFILE 📝

Googlescholar

EDUCATION 🎓

🎓 Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 🧪. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE 🔬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. 🧬💉 In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. 📚🧪 As an educator, she has supervised and trained students, fostering future scientific innovation. 🌿👩‍🏫

CONFERENCE POSTER PRESENTATIONS 📊

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) 💉. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🤝

🎓 Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. 📚 Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. 📝 She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS 🏆

🎓 Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. 🌟🔬 Her work contributes significantly to oncology and neurological research. 🧬💼